Biotechnology, electronics and life science company MOBILion Systems, Inc. announced on Wednesday a collaboration with Dr Oliver Schmitz from the University of Duisburg-Essen, a specialist in analytical chemistry for complex sample analysis.
This partnership highlights MOBILion's commitment to advancing multiomics research through its proprietary SLIM (Structures for Lossless Ion Manipulation) technology.
Dr Schmitz will integrate MOBILion's latest low mass system into his work on complex sample analysis, including Chinese herbal medicine and multidimensional chromatography workflows. The system addresses limitations of traditional LC-MS and ion mobility technologies, enabling precise and efficient metabolomics discovery. Cleaner, more focused data is achieved by reducing overlapping signals, simplifying molecular identification and interpretation.
MOBILion continues to expand its SLIM-based product pipeline, supporting breakthroughs in proteomics, lipidomics, glycomics, and metabolomics. This collaboration builds on the company's recent progress in proteomics applications and commercial platform development.
AstraZeneca secures US approval for Imfinzi–BCG regimen in high‑risk bladder cancer
Innovent Biologics and Pfizer agree global collaboration to develop innovative oncology medicines
FDA approves TREMFYA label expansion
GSK reports positive phase III data for bepirovirsen in chronic hepatitis B
Sanofi's venglustat receives FDA priority review for type 3 Gaucher disease
Ribo submits Phase 2 trial application for RBD1119 to European regulator
US FDA extends review timeline for AstraZeneca's camizestrant application
Circio and AaviGen partner to develop next-generation gene therapies for heart disease
CordenPharma acquires AmbioPharm, expanding peptide API capacity
OncoZenge secures European approval for Phase III BEAM-Pain trial of BupiZenge
AstraZeneca's Enhertu recommended for EU approval in HER2-positive solid tumours
Lundbeck's Vyepti (eptinezumab) receives South Korean approval for preventive treatment of migraine